Substance Use Disorder
Latest News
Advertisement
Latest Videos
Podcasts
CME Content
Advertisement
More News
GLP-1 drugs like semaglutide may curb alcohol and opioid cravings, as trials expand, combos emerge, and interaction risks surface.
Explore how neuromelanin-sensitive MRI noninvasively tracks long-term dopamine and noradrenaline system changes.
ASAM’s new youth SUD criteria help clinicians deliver developmentally tailored, prevention-first care with coordinated family and community supports.
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves Oveporexton for Narcolepsy Type 1, First Drug to Treat Full Range of NT1 Symptoms
2
Postpartum Psychosis on Trial: What the Lindsay Clancy Case Can Teach Us
3
Xanomeline/Trospium in Treatment-Refractory Bipolar I Disorder With Psychosis: A Case Report of Rapid Agitation Control and Functional Improvement
4
Bringing Wearable Data Into Psychiatric Care: Amae Health Partners With Google Health Enterprise to Improve Outcomes
5